SMS Pharmaceuticals Ltd — Major Shareholding Notification 2020

Nov 27, 2020

Registered & Corporate Office: Plot No. 72, H. No. 8-2-334/3 & 4, Road No.5, Opp. SBI Executive Enclave, Banjara Hills, Hyderabad - 500 034, Telangana, INDIA. Tel : +91-40-2525 9999, Fax : +91 -40-25259889 CIN : L24239TG1987PLC008066 Email: info@smspharma.com, www.smspharma.com

2ih November, 2020

To BSE Limited, Listing Department, P J Towers, Da lal Street, Mumbai -400 001. Scrip code: 532815

National Stock Exchange of India Limited, Listing Department, "Exchange Plaza", Bandra-Kurla Complex, Bandra (El, Mumbai - 400 051. Trading Symbol: SMSPHARMA

Dear Sir I Madam,

SUB: DISCLOSURE OF INTER-SE TRANSFER OF SHARES BETWEEN PROMOTERS I PROMOTER GROUP IN ACCORDANCE WITH REGULATION 10(5) OF SEBI (SAST) REGULATIONS, 2011.

In compliance with . Regulation 10(5) of SEBI (SAST) Regulations, 2011, We would like to inform your good office that Acquirers, being a part of Promoter Group of SMS Pharmaceuticals Limited (herein after referred as lithe Company") intends t o acquirer 87,57,500 (Eighty Seven Lakhs Fifty Seven Thousand and Five Hundred) Equity Shares of the Company by way of inter-se transfer on or after December 7, 2020, in terms of Regulation 10(1)(a)(ii) of SEBI (SAST), Regulations2011 by way of onmarket.

Name of Person (Acquirer)	Name of the (Seller)	ofNo.sharestoproposedbe	of%shareholding
		transferred
Mr. Vamsi Krishna Potluri	Mr. TVVSN Murthy	42,24,680	4.99
	TVVSN Murthy - HUF	5,86,340
	Mrs. Annapurna Talluri	5,06,760	0.60
Mr. Ramesh Babu Potluri	Mrs. Annapurna Ta lluri	14,68,100	1.73
Mrs. Hima Bindu Potluri	Mrs. Annapurna Talluri	13,90,480	1.64
Mis Potluri Infra Projects LLP	5,81,140	0.69
Total		87,57,500	10.35

The details of the same are mentioned below:

This being an "Interse" transfer of shares amongst Promoter Group, the same falls within the exemptions (under Regulation 10(1)(a)(ii) provided under SEBI (SAST) Regulation's, 2011). The aggregate holding of Promoter and Promoter Group before and after the above inter se transactions remains the same.

In this connection, disclosure under Regulation 10(5) for the above said acquisition in prescribed format, as submitted by the Acquirer is enclosed herewith for your kind information and records.

Thanking you,

~ S Venkatish

V Company secretary

Encl: al a

Date: 2ih November, 2020

From Mr. Ramesh Babu Potluri Mrs. Hima Bindu Potluri Mr. Vamsi Krishna Potluri M/s Potluri Infra Projects LLP (Promoters & Promoter group of SMS Pharmaceuticals Limited) Plot. No. 265 Q, Road No. 10, Jubilee Hills, Hyderabad - 500033 TS

To

BSE Limited, Listing Department, P J Towers, Dalal Street, Mumbai - 400001. Scrip code: 532815

National Stock Exchange of India Limited, Listing Department, "Exchange Plaza", Bandra-Kurla Complex, Bandra (El, Mumbai - 400 051. Trading Symbol: SMSPHARMA

Email: corp.relations@bseindia.com corp.comm@bseindia.com

Email: takeover@nseindia.com

To,

Company Secretary & Compliance officer SMS Pharmaceuticals Limited Plot.no. 72, H.No. 8-2-334/3&4, Road No.5, Opp. SBI Executive Enclave, Banjara Hills Hyderabad 500034.

Dear Sir,

SUB: DISCLOSURE(S) UNDER REGULATION 10(5) OF THE SEBI (SAST) REGULATION, 2011 Ref: Name of the Target Company: SMS Pharmaceuticals Limited - ISIN: INE812G01025.

We hereby submit disclosures as required under Regulation 10(5) of SAST Regulations, 2011 for acquisition of 87,57,000 Equity shares of SMS Pharmaceuticals Limited.

Kindly take the same on records and acknowledge the receipt of the same.

Yours truly, ThankinV

Ramesh Babu Potluri Hima Bindu Potluri

Q Va hna Potluri

Q Va na Potluri

Encl as above

Format for Disclosures under Regulation 10(5) - Intimation to Stock Exchanges in respect of acquisition under Regulation 1O{l)(a) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations. 2011

1.		Name of the Target Company (TC)	SMS Pharmaceuticals Limited
2.	Name of the acquirer(s)		!Mr. Ramesh Babu Potluri
			iMrs. lEma Bindu Potluri
			!Mr. Vamsi Krishna Potluri
			iM/s Potluri Infra Projects LLP
3.		Whether the acquirer(s) is/ are promoters of the IPromoter and Promoter Group
		TC prior to the transaction. If not. nature of
	relationship or association with the TC or its
	promoters
4.		Details of the proposed acquisition
		a. Name of the person(s) from whom shares areto be acquired		!Mr. TVVSN Murthy
				IrVVSN Murthy - BUF
			iMrs. Annuapurna Talluri
		b. Proposed date of acquisition	bn or after December 1.2020
		c. Number of shares to be acquired from each	Sl no.	Name of seller	No of shares
		person mentioned in 4(a) above	1)	Mr. TVVSN Murthy	4805820(5.68%)
			2)	TVVSN Murthy - BUF	586340(0.69%)
			3)	Mrs. Annuapurna Talluri	3365340(3.98%)
		d. Total shares to be acquired as % ofcapital of TC	10.35%
		e. Price at which shares are proposed to be		Price not exceeding the limits provided in proviso (i) to
	acquired		Regulation 1O(1)(a) ofthe SEBI SAST Regulations.
Rationale. if any. for the proposed transferf.			Inter-se transfer of equity shares of SMS Pharmaceuticals
				Limited between members of Promoter and Promoter Group
			Persons acting in concert.
5.			Relevant sub-clause of regulation 1O(1)(a) under Regulation 10(1 )(a)(ii) of the SEBI SAST Regulations.
		which the acquirer is exempted from making
		open offer
6.		If. frequently traded. volume weighted average The Shares of the TC are frequently traded in terms of
			market price for a period of 60 trading days Regulation 2(i)0) of the SEBI SAST Regulations. the Volume
				preceding the date of issuance of this notice as Weighted Average Market Price for a period of 60 trading
	tradedstockexchangewhereonthe			the ~ays preceding the date of issuance of this notice as traded
			maximum volume of trading in the shares of the pn the Stock Exchange where the maximum value of
	TC are recorded during such period.lPeriod is Rs. 90.42/- per shares.			trading in the share of the TC are recorded during such
7.	If in-frequently traded. the price as determined in Not Applicable
		terms of clause (e) of sub-regulation (2) of
	regulation 8.

8.	Declaration by the acquirer. that the acquisition ~e acquisition price would not be higher more than 25% of
	price would not be higher by more than 25% of he price computed in point no. 6 herein above.
		the price computed in point 6 or point 7 as
		applicable.
9.				Declaration by the acquirer. that the transferor [rhe transferors and transferees have complied (during 3
				and transferee have complied I will comply with ~ears prior to the date of the proposed acquisition) I will
		applicable disclosure requirements in Chapter V		omply with applicable disclosure required under Chapter
	of	theTakeover	Regulations.	2011 V of the SEBI SAST Regulations.
		(correspondingprovisions	oftherepealed
		Takeover Regulations 1997)
10.		Declarationbytheacquirer	thatall	the We hereby declare that all the conditions specified under
	conditions specified under regulation lO(l)(a) Regulation 10(1)(a) of the SEBI SAST Regulations with
	with	respect to exemptions		has been duly respect to exemptions has been duly complied with.
		complied with.
11.		Shareholding details		Before the		After the
				proposed		proposed
				transaction		transaction
				No. of shares	%w.r.t	No. of	% w.r.t total
				I/voting rights	total share	shares	share
					capital ofTC	/votingrights	capital ofTC
	a	Acquirer(s) and PACs (other than sellersW)
		Mr. Ramesh Babu Potlurii.		1.40.84.960	16.64%	1.55.53.060	18.37%
		ii.Mrs. Hima Bindu Potluri		1.33.98.360	15.83%	1.4 7.88.840	17.4 7%15.74%
		iii.Mr. Vamsi Krishna Potluri		80,10,590	9.46%	1.33,28.370	7.90%
		iv.M Is Potluri Infra Projects LLP		61.04,100	7.21%	66,85.240
	b	Seller (s)		5467000	6.46%	661180	0.78%
		i.Mr. TVVSN MurthyTVVSN Murthy - HUFii.		586340	0.69%	-	-
		iii.Mrs. Annuapurna Talluri		3365340	3.98%	-	-
	q"V
							Ramesh Babu Potluri

apotluri

J-Ilnr"L.O.. ~ ~ ncL u . P

Hima Bindu Potluri

Place, Hyderabad Date, November 27.2020